Genomic Sequencing Of Tumor Sample Not Patentable, Petitioner Says
ALEXANDRIA, Va. — A cancer diagnostics company accused in Colorado federal court of infringing a method of screening for cancer recurrence maintains in a Nov. 22 filing with the Patent Trial...To view the full article, register now.
Already a subscriber? Click here to view full article